Abstracts

PHASE IIA TRIAL OF ISLATRAVIR QM FOR HIV PrEP: WEEK 24 METABOLIC AND RENAL OUTCOMES

Adverse events (AEs) and long-term toxicities, including weight gain, loss of bone mineral density (BMD), and changes in renal function, have been reported among persons taking approved HIV-1 pre-exposure prophylaxis (PrEP) regimens. Islatravir (ISL) is a nucleoside reverse transcriptase translocation inhibitor under clinical investigation for the treatment and prevention of HIV-1. ISL has a long…

DIFFERENT HIV PROTECTION FOR TRADITIONAL AND MEDICAL CIRCUMCISION IN HPTN 071(PopART)

An important component of combination prevention is voluntary medical male circumcision (VMMC). Inclusion of traditionally circumcised men in VMMC uptake campaigns may be important if traditional male circumcision, widely practiced in sub-Saharan Africa, is less protective than VMMC against HIV acquisition. We used survey data from the Population Cohort of the HPTN 071 (PopART) study…